CM
IMPV

Crestline Management’s Imperva, Inc. IMPV Stock Holding History

Crestline Management’s Portfolio IMPV Stock Details IMPV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-10,000
Closed -$433K – 318
2018
Q1 		$433K Buy
+10,000
New +$449K 0.05% 199
2016
Q4 		– Sell
-3,400
Closed -$183K – 244
2016
Q3 		$183K Buy
+3,400
New +$158K 0.02% 180

Other funds holding IMPV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EC
Eminence Capital New York $4.36B AUM 3.1% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
EM
Elliott Management New York $11.8B AUM 20.29% 1-Year Est. Return
RC
RGM Capital Naples, Florida $2.06B AUM 8.49% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
CTA
Carillon Tower Advisers St. Petersburg, Florida $16.4B AUM 64.75% 1-Year Est. Return

Crestline Management's IMPV Position: Q2 2018 in Review

Crestline Management sold out of Imperva, Inc. (IMPV) in Q2 2018, closing a stake of 10,000 shares — an estimated $433K sold.

Crestline Management first reported a position in IMPV in Q3 2016 and held it in 2 quarters. The position peaked at $433K in Q1 2018. 188 funds tracked by Wall St. Rank hold IMPV as of Q2 2018.

  • Crestline Management reported no remaining Imperva, Inc. position as of Q2 2018 after selling out during the quarter.
  • Crestline Management sold 10,000 Imperva, Inc. shares in Q2 2018, an estimated $433K.
  • Crestline Management first reported a position in Imperva, Inc. in Q3 2016 and held it in 2 quarters.
  • Crestline Management's Imperva, Inc. position peaked at $433K in Q1 2018.
  • 188 funds tracked by Wall St. Rank held Imperva, Inc. as of Q2 2018.

Based on Crestline Management's 13F filing for Q2 2018, filed 14 Aug 2018.